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Baltimore, Md
Objectives: The impact of risk factors upon perioperative mortality might differ for patients undergoing open vs
endovascular repair (EVAR) of abdominal aortic aneurysms (AAA). In order to investigate this, we developed a
differential predictive model of perioperative mortality after AAA repair.
Methods: A total of 45,660 propensity score matched Medicare beneficiaries undergoing elective open or endovascular
AAA repair from 2001 to 2004 were studied. Using half the dataset we developed a multiple logistic regression model for
a matched cohort of open and EVAR patients and used this to derive an easily evaluable risk prediction score. The
remainder of the dataset formed a validation cohort used to confirm results.
Results: The derivation cohort included 11,415 open and 11,415 endovascular repairs. Perioperative mortality was 5.3%
and 1.8%, respectively. Independent predictors of mortality (relative risk [RR], 95% confidence interval [CI]) were open
repair (3.2, 2.7-3.8); age (71-75 years 1.2, 0.9-1.6; 76-80 years 1.9, 1.4-2.5;>80 years 3.1, 2.4-4.2); female gender (1.5,
1.3-1.8); dialysis (2.6, 1.5-4.6); chronic renal insufficiency (2.0, 1.6-2.6); congestive heart failure (1.7, 1.5-2.1); and
vascular disease (1.3, 1.2-1.6). There were no differential predictors of mortality across the two procedures. A simple
scoring system was developed from a logistic regression model fit to both endovascular and open patients (area under the
receiver operator curve [ROC] curve of 72.6) from which low, medium, and high risk groups were developed. The
absolute predicted mortality ranged from 0.7% for an EVAR patient <70 years of age with no comorbidities to 38% for
an open patient >80 with all the comorbidities considered. Although relative risk was similar among age groups, the
absolute difference was greater for older patients (with higher baseline risk).
Conclusion: Mortality after AAA repair is predicted by comorbidities, gender, and age, and these predictors have similar
effects for both methods of AAA repair. This simple scoring system can predict repair mortality for both treatment
options and thus may help guide clinical decisions. ( J Vasc Surg 2009;50:256-62.)Open abdominal aortic aneurysm (AAA) repair has
been shown to have higher early mortality compared to
endovascular (EVAR) repair.1-3 For this reason, when an-
atomic factors allow, there is a mounting preference toward
using EVAR, particularly for older and sicker patients who
would be less likely to survive open surgery. Long-term
outcomes, however, eventually converge with similar sur-
vival after several years of follow-up.1,4,5 Also favoring
endovascular repair are shorter duration hospital stays,
quicker functional recovery, fewer postoperative complica-
tions, fewer laparotomy-related reinterventions, and lower
initial costs. Follow-up monitoring regimens, however, are
more intensive after endovascular repair, and aneurysm-
related re-interventions are more frequent.1 Thus, the de-
Beth Israel Deaconess Medical Center,a the Department of Health Care
Policy, Harvard Medical School,b Centers for Medicare and Medicaid
Services,c and the Department of Health Care Policy, Harvard Medical
School.d
Competition of interest: none.
Presented at the Thirty-fifth New England Society for Vascular Surgery
Annual Meeting, Newport, RI, October 4, 2008.
Reprint requests: Marc Schermerhorn, MD, Beth Israel Deaconess Medical
Center, 110 Francis St, Suite 5B, Boston, MA 02215 (e-mail: mscherm@
bidmc.harvard.edu).
0741-5214/$36.00
Copyright © 2009 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2009.01.044
256cision to pursue open vs endovascular repair hinges on
many factors and is not always straightforward.
Using comprehensive data on elderly enrollees in the
Medicare program, we previously found that in-hospital
mortality for endovascular AAA repair and open repair were
1.2% and 4.8%, respectively, but that early mortality differ-
ences increased with age.1 What remains unknown, how-
ever, is if there are specific clinical factors that might differ-
entially impact early survival after open and endovascular
AAA repair and thus influence the decision to perform one
procedure over the other.
Predictive risk models such as the Glasgow Aneurysm
Score (GAS), Leiden Score, and Hardman Index have been
derived for open AAA repair and, while they have variable
utility for open repair, they over-predict mortality in the
EVAR population.6-13 To our knowledge, no independent
predictive models have been devised from EVAR data nor
have these studies attempted to assess outcomes in terms of
whether factors may differentially affect mortality after
EVAR vs open repair. We therefore sought to identify
clinical and demographic factors related to perioperative
mortality for both types of repairs and to identify specifi-
cally predictors with a differential effect to the extent that
they exist. The results of this analysis will provide a clinical
tool for the selection of patients best suited for endovascu-
lar or open repair and will assist clinicians in estimating
lasty;
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AAA repair.
METHODS
Overview. We used data from the Medicare popula-
tion to identify all traditional Medicare beneficiaries who
underwent either open or endovascular repair of an AAA
during the time period from 2001 to 2004. Data from Part
A and B claims as well as the Medicare Denominator file
were used to allow analysis of inpatient, outpatient, and
survival information. Using a split sample approach, we
developed clinical models predicting perioperative mortal-
ity and identified clinical predictors that differentially im-
pacted each of the procedures. The models were validated
on the other portion of the split sample. The study was
approved by the Institutional Review Board at Harvard
Medical School and all analyses were performed by a col-
laborating author (P.C.) at the Centers for Medicare and
Medicaid Services (CMS).
Patients. Using both ICD-9-CM diagnosis and pro-
cedure codes (International Classification of Diseases, 9th
Revision, Clinical Modification) and CPT codes (Current
Procedural Terminology, American Medical Association),
we identified all traditionalMedicare beneficiaries age 67 or
older with at least 2 years of prior Medicare claims who
Table I. Baseline characteristics of the derivation and valid
beneficiaries undergoing endovascular and open repair of a
Variable
Deriva
Endovascular repair
(N  11415)
% of
Age
67-70 years 14.5
71-75 years 29.7
76-80 years 30.6
80 years 25.2
Male 79.9
Female 20.1
Black race 2.7
Comorbidities
Dialysis-dependent endstage renal disease 0.8
Chronic renal insufficiency 4.0
Coronary artery disease
Recent CABG (24 months) 4.4
Recent PTCA (24 months) 5.1
No recent intervention 19.6
Myocardial infarction
6 months 1.8
6-24 months 7.8
Valvular heart disease 10.6
Congestive heart failure 13.3
Peripheral vascular disease 21.6
Cerebrovascular disease 16.5
Vascular disease PVD/CBVD) 31.5
Hypertension 66.3
Diabetes mellitus 16.1
Chronic obstructive pulmonary disease 29.9
CABG, Coronary artery bypass graft; PTCA, percutaneous coronary angiopunderwent either endovascular or open repair of an electiveAAA from 2001 to 2004. Patients with a diagnosis of
ruptured AAA, thoracic aneurysm, thoracoabdominal an-
eurysms, or aortic dissection were excluded along with
patients having procedure codes for repair of the thoracic
aorta or visceral bypass. Also excluded were beneficiaries
enrolled in health maintenance organizations at any time
during the study period and those beneficiaries not enrolled
in Medicare Part B. The patient selection methods are
available in detail elsewhere.1
Predictor variables. We measured clinical co-morbidities
during the 2 years prior to the index admission using a
version of the Elixhauser14 algorithm that was adapted to
also include diagnoses that occurred only in the outpa-
tient setting.14,15 Candidate comorbid conditions in-
cluded were those that were identified in prior studies as
impacting mortality (Table I). Baseline beneficiary de-
mographic characteristics were obtained from the Medi-
care denominator file. Age was categorized as 67-70,
71-75, 76-80, or 80 years and race was classified as
white, black, or other. Prior vascular disease was defined
as either a prior history of cerebrovascular disease or
peripheral vascular disease.
Outcomes. Perioperative mortality was defined as in-
hospital death or death within 30 days of the procedure.
Date of death was identified from the Medicare denomina-
n cohorts of a propensity matched sample of Medicare
inal aortic aneurysms in the 2001-2004 period
ohort Validation cohort
en repair
 11415) P value
Endovascular repair
(N  11415)
Open repair
(N  11415) P value
nts % of patients
14.3 .69 13.6 13.9 .45
29.1 .34 29.8 30.3 .44
32.1 .02 31.6 31.3 .63
24.5 .21 25.1 24.6 .37
80.7 .15 80.7 80.5 .84
19.3 .15 19.4 19.5 .84
2.4 .08 2.6 2.7 .74
0.5 .02 0.8 0.6 .13
4.3 .32 4.0 3.8 .43
6.9 .0001 4.5 6.5 .0001
4.8 .35 4.9 4.8 .74
17.6 .0001 20.4 17.9 .0001
1.9 .62 1.9 1.7 .14
7.9 .68 8.2 8.0 .63
10.4 .71 11.3 10.5 .04
13.1 .70 13.3 13.1 .70
21.2 .52 21.0 20.4 .27
16.5 .94 16.3 16.2 .86
31.4 .84 31.0 30.3 .23
65.8 .36 66.0 65.8 .78
15.7 .35 15.3 15.7 .34
29.3 .34 29.5 30.1 .33
PVD, peripheral vascular disease; CBVD, cerebrovascular disease.atio
bdom
tion c
Op
(N
patietor file. We included in-hospital deaths that occurred more
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number of deaths occur in this period and these deaths were
thought to be directly related to the procedure or compli-
cations from the procedure.16
Creating matched cohorts. In order to assure that
the populations undergoing each procedure were compa-
rable, we created matched cohorts of patients using a
propensity score approach. As explanatory variables we
used available baseline beneficiary demographic and clinical
characteristics obtained from claims during the 2-year pe-
riod prior to and not including the index admission. We
measured clinical co-morbidities using a version of the
Elixhauser algorithm as noted above.14,15 We matched
each beneficiary who underwent endovascular repair to a
beneficiary who underwent open repair based on the esti-
mated propensity score. To ensure close matches we required
the estimated log-odds of endovascular repair between a pa-
tient who underwent endovascular repair and onewho under-
went open repair to be within 0.60 standard deviations. This
value removes approximately 90% of the bias in estimates of
effects due to differences in covariate distributions between
“treatment” and comparison groups.17,18
Statistical analyses. After matching, we randomly di-
vided the study population into derivation and validation
cohorts using a computer generated randomization pro-
gram. The bivariate relationships between perioperative
mortality and categorical variables were compared using 2
tests. All statistical analyses were performed using SAS 9.1
statistical software (SAS Institute Inc, Cary, NC). Using
the derivation cohort, we identified significant variables by
analyzing mortality risk associated with each demographic
and comorbid factor in univariate and multivariate logistic
regression models. This was done separately for both endo-
vascular and open repair. Variables meeting statistical sig-
nificance at the P .10 level were then included as predic-
tor variables in a combinedmodel with endovascular repair.
Interaction terms were tested for each demographic and
comorbid variable to test for differential effects based upon
repair type. The final regression model included all age
categorical variables and all other variables and interaction
terms that remained significant at the P  .05 level. This
final model was then translated into a probability formula,
which we used to derive a simple scoring system. We used
the weighted sum of the predictors from the logistic regres-
sion model multiplied by their regression coefficients, and
then transformed these onto the (0,1) interval to yield a
predicted probability of mortality for each possible combi-
nation of characteristics. To make the predictive model as
easy as possible to present, we compute “scores” for pa-
tients based on the weighted sum as opposed to presenting
the probabilities themselves. We then partitioned the pre-
dictedmortality rates for each repair type into low-, medium-,
and high-risk scores range based on the 25th and 75th
percentiles of their probability distributions as these corre-
sponded to clinically appropriate mortality probability cut-
offs. This assigned 25% of the patients as low risk and 25%
as high risk.We then tested the scoring system using the validation
cohort of our sample by examining the area under the
receiver operator characteristic (ROC) curve (the c-statistic).
A similar area under the curve (AUC) for the derivation and
validation cohorts suggests that the model discriminates
the outcome of interest (mortality) equally well in the two
datasets and that there is no evidence of “overfitting” (ie,
including predictors that correlate with random variation in
the derivation cohort).
RESULTS
We identified a total of 61,598 patients undergoing
repair of an intact AAA during the years 2001 to 2004.
Endovascular repair was performed in 29,542 and open
repair in 32,056. After propensity matching and random-
ization into derivation and validation cohorts, this left a
total of 22,830 patients (11,415 EVAR, 11,415 open
repair) in both the derivation and validation cohorts. The
population characteristics for each repair group within both
cohorts are listed in Table I. About 30% were between the
ages of 71 and 75-years-old and 20% were female. Approx-
imately 8% had suffered a myocardial infarction in the last 2
years and just over 15% had diabetes. There were few
significant differences between the patients undergoing
EVAR or open repair in either the derivation or validation
cohorts. For instance, there were slightly more patients
who had undergone coronary artery bypass graft (CABG)
surgery within the last 2 years in the open as compared to
the EVAR cohorts (4.4% vs 6.9% for the derivation cohort,
P  .001).
Predictors of mortality in patients undergoing
EVAR and open repair. Overall perioperative mortality
over the study period was 1.8% (95% confidence interval
[CI] 1.5-2.0) after EVAR, and 5.3% (95% CI 4.9-5.7) after
open repair. There were no significant differences in mor-
tality from 2001 to 2004 for either method of repair. The
relative risk (RR) of mortality after open repair vs EVAR
was similar across all age groups, ranging from 2.6 to 3.2.
The absolute mortality difference between open and EVAR
was lowest for the youngest age group at 1.6% and rose
incrementally with age to a maximum of 6.1% for patients
over 80 years of age. Mortality was higher for females than
males for both repair types (EVAR RR  2.0, P  .0001;
open RR  1.5, P  .0001).
Significant univariate predictors of mortality after
EVAR were age, female gender, renal disease, recent myo-
cardial infarction, congestive heart failure, vascular disease,
valvular heart disease, and chronic obstructive pulmonary
disease (Table II). Coronary artery disease with recent
percutaneous coronary angioplasty was associated with
lower mortality.
Comparatively, univariate predictors of mortality after
open repair included age, female gender, renal disease,
coronary artery disease without a recent procedure, conges-
tive heart failure, vascular disease, valvular heart disease,
hypertension, diabetes mellitus, and chronic obstructive
pulmonary disease (Table II). Coronary artery disease with
a recent coronary artery bypass surgery was associated with
lasty;
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similar effects for both EVAR and open repair while some
varied by repair method, suggesting it would be worthwhile
to test the associated interaction effects.
Multivariable predictor variables of mortality after
open repair and EVAR. Open repair was a significant
predictor of mortality with a threefold increase compared
to EVAR (Table III). The most significant predictors of
mortality (OR, 95% CI) were open repair (3.2, 2.7-3.8),
age 80 years (3.1, 2.4-4.2), and endstage renal disease
(2.6, 1.5-4.6). Age from 76-80 (1.9, 1.4-2.5), female
Table II. Univariate predictors of mortality after endovasc
beneficiaries in the 2001-2004 period
Variable
Endo
OR 9
Age (vs 67-70 years)
71-75 years 1.1 0.
76-80 years 1.7 1.
80 years 3.0 1.
Female 2.1 1.
Black race 1.1 0.
Comorbidities
Dialysis-dependent endstage renal disease 4.0 1.
Chronic renal insufficiency 3.7 2.
Coronary artery disease
Recent CABG (24 months) 1.1 0.
Recent PTCA (24 months) 0.4 0.
No recent intervention 1.2 0.
Myocardial infarction
Within 6 months 2.6 1.
Within 6-24 months 1.2 0.
Valvular heart disease 2.1 1.
Congestive heart failure 2.4 1.
Vascular disease (PVD/CBVD) 1.6 1.
Hypertension 1.3 0.
Diabetes mellitus 1.0 0.
Chronic obstructive pulmonary disease 1.4 1.
CABG, Coronary artery bypass graft; PTCA, percutaneous coronary angiop
Table III. Pooled multivariate predictors of mortality
after endovascular and open abdominal aortic aneurysm
repair in Medicare beneficiaries in the 2001-2004 period
Variable OR 95% CI P value
Open Repair 3.2 2.7 3.8 .0001
Age (vs 67-70 years)
71-75 years 1.2 0.9 1.6 .34
76-80 years 1.9 1.4 2.5 .0001
80 years 3.1 2.4 4.2 .0001
Female 1.5 1.3 1.8 .0001
Dialysis dependent endstage
renal disease 2.6 1.5 4.6 .001
Chronic renal insufficiency 2.0 1.6 2.6 .0001
Congestive heart failure 1.7 1.5 2.1 .0001
Vascular disease (peripheral
arterial or cerebrovascular
disease) 1.3 1.2 1.6 .0001
OR, Odds ratio; CI, confidence interval.gender (1.5, 1.3-1.8), chronic renal insufficiency (2.0, 1.6-2.6), congestive heart failure (1.7, 1.5-2.1), and vascular
disease (1.3, 1.2-1.6) were other significant predictors.
After testing for interactions between the type of repair and
each of the significant predictors, no variables were identi-
fied that had a differential impact between the two repair
types.
Mortality probability. Based on the predictive prob-
abilities of mortality, the differences in absolute mortality
and relative risk between EVAR and open repair were 16%
and 2.4, respectively, for the oldest age group with all other
predictive factors whereas they were 4.3% and 3.1 for the
same age group with no other predictive factors (Table IV).
Conversely, for the youngest age group the absolute mor-
tality difference and relative risk were 11.3% and 2.9 with all
other predictive factors present and 1.3% and 3.2 without
and open abdominal aortic aneurysm repair in Medicare
lar repair Open repair
I P value OR 95% CI P value
1.9 .76 1.2 0.9 to 1.8 .25
2.9 .06 2.2 1.5 to 3.0 .0001
5.0 .0001 3.7 2.7 to 5.2 .0001
2.8 .0001 1.6 1.3 to 1.9 .0001
2.5 .82 1.2 0.7 to 2.0 .47
9.2 .01 2.7 1.3 to 5.6 .05
5.7 .0001 2.2 1.7 to 3.0 .0001
2.1 .72 0.6 0.4 to 0.9 .05
1.0 .05 0.9 0.6 to 1.3 .50
1.7 .25 1.4 1.2 to 1.8 .001
5.2 .05 1.1 0.6 to 2.0 .65
2.0 .38 1.1 0.8 to 1.4 .65
3.0 .0001 1.3 1.0 to 1.7 .05
3.4 .0001 2.1 1.7 to 2.6 .0001
2.1 .001 1.6 1.3 to 1.8 .0001
1.7 .14 1.3 1.1 to 1.6 .01
1.5 .91 1.3 1.1 to 1.6 .01
1.9 .05 1.3 1.1 to 1.6 .01
PVD, peripheral vascular disease; CBVD, cerebrovascular disease.
Table IV. Mortality prediction of open vs endovascular
abdominal aortic aneurysm repair by age and comorbidities
based on scoring method
Predicted
mortality
(Maximum
Comorbidities)
Relative
risk
Predicted
mortality
(Minimum
Comorbidities)
Relative
risk
Age Open vs EVAR Open vs EVAR
80 years 38%-16% 2.4 6.3%-2.0% 3.1
76-80 years 27%-10% 2.6 3.9%-1.2% 3.1
71-75 years 19%-6.6% 2.8 2.4%-0.8% 3.2
70 years 16%-5.7% 2.9 2.0%-0.7% 3.2
OR, Odds ratio; CI, confidence interval.ular
vascu
5% C
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mortality probability* was simplified into a risk score as
represented by the following sequence of equations
(I(event)  1 if event is true and 0 otherwise).
(1) Compute patient characteristics effect:
Patient Characteristics  4I (female)  1I (70 age
75)  6I (75 age 80)  11I (age 80).
(2) Compute comorbidity effects:
Comorbidities 9I (end-stage renal disease [ESRD])
7I (chronic renal insufficiency [CRI])  6I (congestive
heart failure [CHF]) 3I (vascular disease).
(3) Treatment effect:
Treatment  12I (open).
(4) Sum effects:
Sum  Patient Characteristics  Comorbidities 
Treatment.
Another way of stating this is to simply sum the coeffi-
cients for each characteristic as shown in Table V. A coef-
ficient of 12 would be attributed to open repair, making
it the highest weighted component. As each characteristic
was equally weighted regardless of repair type, however, it
was decided to apply the effect of open repair on translation
of the score into mortality estimation. The division of low,
medium, and high risk corresponds to score ranges of 3
(low), 3 to 11 (medium), and 11 (high) with respective
mortality probabilities of1%, 1% to 2%, and2% for EVAR
and3%, 3% to 6%, and6% for open repair (Table V).
Validation. The area under the ROC curve for the
predictive probabilities was 72.6 within the derivation co-
*logit(P)5.020.42*Female0.15*Age(70 to 75)0.63*Age(75 to
80)1.14*Age(80)0.71*CRI0.95*ESRD0.55*CHF0.30*
Table V. Scoring method for prediction of mortality
after endovascular or open abdominal aortic aneurysm
repair
Risk factor Score
AGE
80 11
76-80 6
71-75 1
Female 4
Renal failure
Dialysis dependent 9
No dialysis 7
CHF 6
PVD or CBVD 3
Total score 
Risk Score range
Open EVAR
Predicted mortality Predicted mortality
High 11 6.3% 2%
Medium 3-11 2.8-6.3% 0.9-2.0%
Low 3 2.8% 1%
CHF, Congestive heart failure; PVD, peripheral vascular disease; CBVD,
cerebrovascular disease.Vascular Disease1.17*Open Repair.hort and 71.8 within the validation cohort. Applying the
cutoff value of the high-risk group, there was a 56.7 and
68.0 sensitivity and specificity for open patients and a 61.2
and 66.8 sensitivity and specificity for EVAR patients for
prediction of mortality. The corresponding values on the
validation cohort were 53.8 and 67.9 for open patients and
58.6 and 66.5 for EVAR patients. Like the AUC, the
sensitivity and specificity values are almost as high in the
validation cohort as in the derivation cohort essentially
ruling out over-fitting and providing validation for the
model.
DISCUSSION
In this study, we used a comprehensive dataset of
Medicare patients undergoing intact AAA repair to develop
a risk prediction model based on preoperative characteris-
tics that would be applicable to patients undergoing either
open or endovascular repair. We found the absolute mor-
tality of open repair to be greater than that of endovascular
repair by a factor of threefold for all patients with mortality
further predicted by age, female gender, and selected co-
morbidities. There were no relative differences in predictors
of perioperative mortality between the two repair ap-
proaches. Our scoring system classifies patients into three
risk classes (depending on the procedure) that can be easily
calculated using available clinical or administrative data.
Previous studies have used administrative data to de-
velop predictors of mortality after AAA repair and others
have created risk models for mortality associated with AAA
repair using clinical cohorts. These studies have been lim-
ited by examining open or endovascular repair alone, ex-
amining both procedures without differentiation, or by
using datasets that lack prior data that can be used to
differentiate pre-existing conditions from complications
occurring within the hospitalization.6-8,19-24
Multivariate statistical models from administrative da-
tabase studies generally find age and female gender to be
important predictors, but have shown variable results for
other clinical comorbidities dependent upon the database
used and inclusion of open repair and/or EVAR.19-24 Hua
et al19 used the National Surgical Quality Improvement
Program-Private Sector database, which uses nurse chart
review for data entry and thus has more reliable comorbid-
ity data, and found that open repair, age, angina, poor
functional status, recent weight loss, and dialysis were all
associated with increased mortality when including both
methods of repair.
As we have done here, other studies have translated risk
prediction models into clinical scoring systems to provide
estimates of an individual’s predicted mortality after repair.
These prediction models, however, were all derived from
cohorts restricted to open AAA repair. A few of the more
well-known are the GAS, the Leiden Score, and the Hard-
man Index.8-10 It is important to recognize that there may
be considerable limitations to these when looking at mod-
ern elective AAA repair, because of the significant mortality
differences when including EVAR.9-13 For instance, the
GAS was developed from a cohort of 268 open AAA repairs
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group was 20% (8.6% for intact AAA repairs). Age (in-
cluded as a continuous variable), is the most significant
factor in this scoring model.6,11,12,25 Nesi et al25 showed
that age alone was at least as good a predictor of mortality
as the GAS after elective open AAA repair.
The Leiden Score was developed in 1995 from a cohort
of 238 patients undergoing open AAA repair as well as a
meta-analysis of published literature. Overall mortality in
the Leiden data were 7.3% and 6.8% depending on the data
source, which more closely approximates current results of
elective open AAA repair.8 This mortality rate, however, is
still substantially higher than we observed in our more
recent Medicare cohort and from recent Nationwide In-
patient Sample (NIS) population data.1,22,26 Faizer et al11
performed a comparison of both of these scoring methods
to evaluate their applicability to mortality prediction for
EVAR. The GAS was found to have a c-statistic of 0.47 for
EVAR showing poor predictive ability. Although theM-LS
had a c-statistic of 0.7, all of the deaths occurred in the
highest quartile of the score, so this was not an effective way
of distinguishing risk factors for most of the population
undergoing repair.
Similarly, some scoring systems have been applied ret-
rospectively to participants in randomized clinical trials
including the UK EVAR trials and the Dutch Randomized
Endovascular Aneurysm Management (DREAM) trial.
Baas et al9 used the GAS scoring model to predict mortality
in patients from the DREAM trial. They found that a
higher GAS was associated with increased 30-day mortality
in open repair but not EVAR. Brown et al27 used the
Customized Probability Index score to assess whether pa-
tient fitness determined the relative benefits of open or
endovascular repair within the EVAR I trial. The study
found that only patients receiving scores corresponding to
the fittest group had a 30-day mortality benefit from EVAR
vs open repair (OR 0.24, P .03) and that no group had a
4-year mortality benefit. While these show that scoring
models may be useful in preoperative risk stratification
before AAA repair, the trials and subsequent tests of score
models were relatively small compared to our current study
(35 deaths in 1205 patients in EVAR-1, 10 deaths in 345
patients in DREAM vs 810 deaths in 22,830 patients in the
current study). We have also specifically included repair
type as a preoperative variable and tested for interaction
effects to ensure that the other preoperative factors have the
same predictive effect across both repair types.
An area under the ROC curve of 0.73 implies that the
model has an approximate 73% chance of correctly classify-
ing into the high risk category a randomly selected patient
who dies compared to one who survives. Given the rela-
tively low mortality now associated with AAA repair, a
model with a high sensitivity is nearly impossible and, given
the inverse relationship of sensitivity and specificity, would
minimize its ability to identify a low risk population. As the
goal of this model is to predict risk categories, we believe
this provides a useful tool that could aid in patient discus-
sions and clinical decision-making.Limitations. We used administrative data to measure
comorbidities that are dependent upon accurate coding of
diagnoses and procedures. The dataset also does not have
preoperative laboratory results or information on patient
symptoms. Additionally, there are no anatomic descriptive
data apart from the diagnosis coding for aneurysm location
as “abdominal,” thus we cannot control for anatomic fea-
tures such as aneurysm diameter, neck length, or level of
clamp placement. A significant benefit of Medicare data vs
other administrative data is that with the addition of Part B
(physician claims) and denominator files, we have universal
pre-existing patient data that was input by physicians and
complete mortality data during the follow-up period. CPT
coding is more detailed than ICD-9 coding which allows
for greater accuracy and specificity for identifying both
procedures and diagnoses. We excluded patients with CPT
codes for concomitant visceral-renal bypass or thoracoab-
dominal aneurysm to exclude suprarenal aneurysm repair.
Incorporating prior claims data allowed us to measure
comorbidities reliably and made it possible to distinguish
comorbidities from complications. It is also important to
recognize that this study examined perioperative mortality
(30-day and in-hospital). These results, therefore, cannot
be used to predict longer term survival differences.
A further limitation of applying scores developed for
open repair to endovascular repair and vice versa is that such
applications may be inappropriate due to the differing
candidate populations.28 To address this issue, we created
carefully matched populations of patients undergoing each
of the procedures. Based on age and other predictors, some
patients are only considered candidates for EVAR, while
previously younger and healthier patients have preferen-
tially been offered open repair. This allows our model to be
relevant for clinical decision-making in patients who are
reasonable candidates for either type of repair in order to
determine differences in predicted mortality. Given our
requirement for 2 years of preoperative data, the youngest
patients in this study are 67 years of age. Increasing age is a
major predictor of perioperative mortality compared to
patients younger than 70-years-old. If younger patients
were included, it is likely that age would be an even stronger
predictor but it has to be recognized that this model was
developed from the Medicare population and may not be
applicable to younger patients.
CONCLUSION
Endovascular AAA repair has significantly lower peri-
operative mortality than open AAA repair (by threefold) for
all ages and comorbid conditions. Older age, female gen-
der, renal disease, congestive heart failure (CHF), and
vascular disease increases the relative mortality risk equally
for either repair method. Given a higher baseline mortality
of open repair, absolute mortality increases as more risk
factors are added, making the absolute benefit of EVAR
greater. We detail a preoperative scoring system for mortal-
ity risk prediction that may be used in the clinical setting to
estimate the risk of mortality for any patient eligible for
open and EVAR.
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